Sign in Sign up for free

Free Stock Screener

Load
Save
Create a watchlist Help
 
–
×
–
×
–
×
–
×
–
×
–
×
–
×
–
day ×
–
day ×
–
% ×
–
% ×
×
–
×
–
×
–
×
–
×
–
×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
day ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
×
–
% ×
–
×
–
×
–
% ×
–
×
–
×
–
×
–
×
–
×

FCCY
1st Constitution Bancorp
Compare

Market cap $286.84M
Enterprise value N/A
Revenue N/A
EBITDA N/A
Income $21.576M
Revenue Q/Q 1.93%
Revenue Y/Y 17.86%
P/E 13.23
Forward P/E N/A
EV/Sales 4.68
EV/EBITDA N/A
EV/EBIT 13.88
PEG 1.03
Price/Sales 3.93
P/FCF 3.34
Price/Book 1.53
Book/Share 18.18
Cash/Share N/A
FCF yield 29.93%
Employees 211
RPE N/A
Volume 596.162k / 0.000
Relative vol. N/A
EPS 2.10
EPS Q/Q 10.42%
Est. EPS Q/Q -25.42%
Profit margin N/A
Oper. margin 42.94%
Gross margin N/A
EBIT margin 40.23%
EBITDA margin 38.77%
Ret. on assets 1.15%
Ret. on equity 11.30%
ROIC 1.46%
ROCE 1.54%
Debt/Equity N/A
Net debt/EBITDA 16.16
Current ratio N/A
Quick ratio N/A
Volatility 1.60%
Beta 0.00
RSI 72.83
Range $26.77 – $27.88
52 weeks $27.79 – $27.79
SMA 50 $28 +0.00%
SMA 200 $28 +0.00%
1 year target $16 -44.22%
Mean Recomm. N/A
Insider ownership 12.72%
Inst. ownership 39.98%
Shares outst. 10.322M
Shares float 0.000 0.00%
Short % of float 0.07%
Short ratio 0.51
1 year target $16 -44.22%
Mean Recomm. N/A
Dividend $0.00
Dividend yield 0.00%
Payout ratio 0.00%
Payment date N/A
Ex-dividend date N/A
Earnings date N/A
IPO year 2000
Country United States
Compare with other stocks

ABMD
Abiomed Inc.
Compare

Market cap $17.29B
Enterprise value N/A
Revenue $1.074B
EBITDA $281.669M
Income $266.764M
Revenue Q/Q 7.16%
Revenue Y/Y 10.32%
P/E 64.91
Forward P/E N/A
EV/Sales 15.23
EV/EBITDA N/A
EV/EBIT 47.95
PEG 1.33
Price/Sales 16.10
P/FCF 79.59
Price/Book 11.50
Book/Share 33.13
Cash/Share 18.19
FCF yield 1.26%
Employees 1,725
RPE $622.664k
Volume 15.703M / 0.000
Relative vol. N/A
EPS 5.87
EPS Q/Q 13.64%
Est. EPS Q/Q 0.97%
Profit margin 24.84%
Oper. margin 23.61%
Gross margin 81.32%
EBIT margin 31.76%
EBITDA margin 26.22%
Ret. on assets 16.01%
Ret. on equity 17.75%
ROIC 12.03%
ROCE 21.83%
Debt/Equity 1.10
Net debt/EBITDA -10.98
Current ratio 7.93
Quick ratio 7.17
Volatility 0.57%
Beta 0.00
RSI 76.23
Range $380.55 – $381.28
52 weeks $381.02 – $381.02
SMA 50 $381 +0.02%
SMA 200 $381 +0.00%
1 year target $312 -18.01%
Mean Recomm. N/A
Insider ownership 2.00%
Inst. ownership 94.64%
Shares outst. 45.091M
Shares float 0.000 0.00%
Short % of float 5.58%
Short ratio 6.18
1 year target $312 -18.01%
Mean Recomm. N/A
Dividend N/A
Dividend yield N/A
Payout ratio N/A
Payment date N/A
Ex-dividend date N/A
Earnings date N/A
IPO year 1987
Country United States
Compare with other stocks

XLRN
Acceleron Pharma Inc
Compare

Market cap $10.93B
Enterprise value N/A
Revenue $112.763M
EBITDA -$251.26
Income -$254.85
Revenue Q/Q 51.58%
Revenue Y/Y 6.39%
P/E 0.00
Forward P/E N/A
EV/Sales 91.88
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 96.94
P/FCF N/A
Price/Book 12.78
Book/Share 13.98
Cash/Share 9.66
FCF yield -2.44%
Employees 312
RPE $361.420k
Volume 7.884M / 0.000
Relative vol. N/A
EPS N/A
EPS Q/Q 75.76%
Est. EPS Q/Q -2.11%
Profit margin -226.01%
Oper. margin -226.57%
Gross margin 100.00%
EBIT margin -225.99%
EBITDA margin -222.82%
Ret. on assets -29.70%
Ret. on equity -32.39%
ROIC -23.10%
ROCE -34.89%
Debt/Equity 1.10
Net debt/EBITDA 10.60
Current ratio 12.14
Quick ratio 12.14
Volatility 1.07%
Beta 0.00
RSI 71.18
Range $177.20 – $179.85
52 weeks $178.75 – $178.75
SMA 50 $179 -0.17%
SMA 200 $179 +0.00%
1 year target $132 -26.28%
Mean Recomm. 1.46
Insider ownership N/A
Inst. ownership N/A
Shares outst. 61.156M
Shares float 0.000 0.00%
Short % of float 3.95%
Short ratio 6.39
1 year target $132 -26.28%
Mean Recomm. 1.46
Dividend N/A
Dividend yield N/A
Payout ratio N/A
Payment date N/A
Ex-dividend date N/A
Earnings date N/A
IPO year 2013
Country United States
Compare with other stocks

AGFS
AgroFresh Solutions Inc
Compare

Market cap $154.42M
Enterprise value N/A
Revenue N/A
EBITDA N/A
Income -$59.79
Revenue Q/Q -13.17%
Revenue Y/Y -2.44%
P/E 0.00
Forward P/E N/A
EV/Sales 3.21
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 0.95
P/FCF 12.72
Price/Book 0.89
Book/Share 3.38
Cash/Share N/A
FCF yield 7.86%
Employees 0
RPE N/A
Volume 0.000 / 0.000
Relative vol. N/A
EPS N/A
EPS Q/Q 2.17%
Est. EPS Q/Q -63.64%
Profit margin N/A
Oper. margin 0.76%
Gross margin N/A
EBIT margin -7.26%
EBITDA margin 37.84%
Ret. on assets -4.74%
Ret. on equity -17.18%
ROIC -2.13%
ROCE -1.86%
Debt/Equity N/A
Net debt/EBITDA 21.53
Current ratio 2.39
Quick ratio 2.01
Volatility 0.35%
Beta 0.00
RSI 57.98
Range $2.99 – $3.01
52 weeks $3.00 – $3.00
SMA 50 $3 +0.00%
SMA 200 $3 +0.00%
1 year target $4 +44.33%
Mean Recomm. 2.00
Insider ownership 3.54%
Inst. ownership 74.21%
Shares outst. 53.718M
Shares float 0.000 0.00%
Short % of float 0.61%
Short ratio 17.73
1 year target $4 +44.33%
Mean Recomm. 2.00
Dividend N/A
Dividend yield N/A
Payout ratio N/A
Payment date N/A
Ex-dividend date N/A
Earnings date N/A
IPO year 2014
Country United States
Compare with other stocks

AIMT
Aimmune Therapeutics Inc
Compare

Market cap $2.26B
Enterprise value N/A
Revenue N/A
EBITDA N/A
Income -$287.03
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E 0.00
Forward P/E N/A
EV/Sales 3,769.86
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 3,832.47
P/FCF N/A
Price/Book 17.87
Book/Share 1.59
Cash/Share N/A
FCF yield -10.38%
Employees 0
RPE N/A
Volume 2.928M / 0.000
Relative vol. N/A
EPS N/A
EPS Q/Q 4.95%
Est. EPS Q/Q -6.80%
Profit margin N/A
Oper. margin -49,193.39%
Gross margin N/A
EBIT margin -47,729.39%
EBITDA margin -42,733.57%
Ret. on assets -92.73%
Ret. on equity -170.95%
ROIC -89.30%
ROCE -85.16%
Debt/Equity N/A
Net debt/EBITDA 2.53
Current ratio 7.53
Quick ratio 7.40
Volatility 8.35%
Beta 0.00
RSI 28.78
Range $5.22 – $5.45
52 weeks $28.40 – $28.40
SMA 50 $34 -21.44%
SMA 200 $34 -21.44%
1 year target $33 +17.46%
Mean Recomm. N/A
Insider ownership N/A
Inst. ownership N/A
Shares outst. 65.450M
Shares float 0.000 0.00%
Short % of float 9.03%
Short ratio 0.99
1 year target $33 +17.46%
Mean Recomm. N/A
Dividend N/A
Dividend yield N/A
Payout ratio N/A
Payment date N/A
Ex-dividend date N/A
Earnings date N/A
IPO year 2015
Country United States
Compare with other stocks

ALXN
Alexion Pharmaceuticals Inc.
Compare

Market cap $40.34B
Enterprise value N/A
Revenue $6.262B
EBITDA $3.180B
Income $681.800M
Revenue Q/Q 13.27%
Revenue Y/Y 18.24%
P/E 58.49
Forward P/E N/A
EV/Sales 6.32
EV/EBITDA N/A
EV/EBIT 51.25
PEG 1.17
Price/Sales 6.47
P/FCF 13.55
Price/Book 3.46
Book/Share 52.72
Cash/Share 15.70
FCF yield 7.38%
Employees 2,525
RPE $2.480M
Volume 3.000 / 0.000
Relative vol. N/A
EPS 3.12
EPS Q/Q 9.32%
Est. EPS Q/Q 7.07%
Profit margin 10.89%
Oper. margin 47.41%
Gross margin 90.94%
EBIT margin 12.15%
EBITDA margin 50.79%
Ret. on assets 10.08%
Ret. on equity 4.43%
ROIC 3.78%
ROCE 4.42%
Debt/Equity 1.50
Net debt/EBITDA -0.25
Current ratio 4.52
Quick ratio 3.47
Volatility 1.17%
Beta 0.00
RSI 52.18
Range $180.21 – $182.67
52 weeks $183.08 – $183.08
SMA 50 $183 +0.32%
SMA 200 $183 -0.02%
1 year target $146 -20.05%
Mean Recomm. 1.92
Insider ownership 0.34%
Inst. ownership 88.27%
Shares outst. 221.019M
Shares float 0.000 0.00%
Short % of float 3.84%
Short ratio 4.24
1 year target $146 -20.05%
Mean Recomm. 1.92
Dividend N/A
Dividend yield N/A
Payout ratio N/A
Payment date N/A
Ex-dividend date N/A
Earnings date N/A
IPO year 1996
Country United States
Compare with other stocks

ABTX
Allegiance Bancshares Inc
Compare

Market cap $830.94M
Enterprise value N/A
Revenue $262.048M
EBITDA $114.145M
Income $75.712M
Revenue Q/Q -5.69%
Revenue Y/Y 5.92%
P/E 11.13
Forward P/E N/A
EV/Sales 3.72
EV/EBITDA N/A
EV/EBIT 9.45
PEG N/A
Price/Sales 3.54
P/FCF 8.12
Price/Book 1.02
Book/Share 40.90
Cash/Share N/A
FCF yield 12.37%
Employees 598
RPE $438.207k
Volume 1.609M / 0.000
Relative vol. N/A
EPS 3.74
EPS Q/Q -28.57%
Est. EPS Q/Q -53.76%
Profit margin 28.89%
Oper. margin 44.40%
Gross margin 98.60%
EBIT margin 39.35%
EBITDA margin 43.56%
Ret. on assets 1.14%
Ret. on equity 10.13%
ROIC 1.52%
ROCE 1.38%
Debt/Equity 9.54
Net debt/EBITDA -16.63
Current ratio N/A
Quick ratio N/A
Volatility 2.24%
Beta 0.00
RSI 40.87
Range $41.21 – $42.57
52 weeks $41.63 – $41.63
SMA 50 $42 +0.00%
SMA 200 $42 +0.00%
1 year target $30 -27.34%
Mean Recomm. 3.00
Insider ownership 6.90%
Inst. ownership 61.52%
Shares outst. 19.960M
Shares float 0.000 0.00%
Short % of float 5.28%
Short ratio 12.92
1 year target $30 -27.34%
Mean Recomm. 3.00
Dividend $0.00
Dividend yield 0.00%
Payout ratio 0.00%
Payment date N/A
Ex-dividend date N/A
Earnings date N/A
IPO year 2015
Country United States
Compare with other stocks

AMAG
AMAG Pharmaceuticals, Inc.
Compare

Market cap $477.47M
Enterprise value N/A
Revenue $326.546M
EBITDA N/A
Income -$227.96
Revenue Q/Q 10.67%
Revenue Y/Y -6.73%
P/E N/A
Forward P/E N/A
EV/Sales 1.99
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 1.57
P/FCF N/A
Price/Book 3.03
Book/Share 8.24
Cash/Share N/A
FCF yield -4.76%
Employees 440
RPE $742.150k
Volume 4.217M / 0.000
Relative vol. N/A
EPS N/A
EPS Q/Q -383.33%
Est. EPS Q/Q -114.29%
Profit margin N/A
Oper. margin -71.96%
Gross margin N/A
EBIT margin -66.23%
EBITDA margin -33.61%
Ret. on assets -30.45%
Ret. on equity -86.41%
ROIC -44.83%
ROCE -35.20%
Debt/Equity N/A
Net debt/EBITDA -5.97
Current ratio 1.75
Quick ratio 1.61
Volatility 94.86%
Beta N/A
RSI 97.78
Range $341.28 – $344.07
52 weeks $25.00 – $25.00
SMA 50 $14 +45.00%
SMA 200 $14 +45.00%
1 year target $13 -47.52%
Mean Recomm. N/A
Insider ownership N/A
Inst. ownership N/A
Shares outst. 34.725M
Shares float 33.751M 97.20%
Short % of float 38.03%
Short ratio 1.83
1 year target $13 -47.52%
Mean Recomm. N/A
Dividend N/A
Dividend yield N/A
Payout ratio N/A
Payment date N/A
Ex-dividend date N/A
Earnings date N/A
IPO year 1986
Country United States
Compare with other stocks

ASRVP
Ameriserv Financial Inc
Compare

Market cap N/A
Enterprise value N/A
Revenue N/A
EBITDA N/A
Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E 0.00
Forward P/E N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales N/A
P/FCF N/A
Price/Book N/A
Book/Share N/A
Cash/Share N/A
FCF yield N/A
Employees 314
RPE N/A
Volume 1.092k / 0.000
Relative vol. N/A
EPS N/A
EPS Q/Q N/A
Est. EPS Q/Q N/A
Profit margin N/A
Oper. margin N/A
Gross margin N/A
EBIT margin N/A
EBITDA margin N/A
Ret. on assets N/A
Ret. on equity N/A
ROIC N/A
ROCE N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Current ratio N/A
Quick ratio N/A
Volatility 0.79%
Beta 0.00
RSI 69.04
Range $25.48 – $27.31
52 weeks $27.31 – $27.31
SMA 50 $27 +0.00%
SMA 200 $27 +0.00%
1 year target N/A
Mean Recomm. N/A
Insider ownership N/A
Inst. ownership N/A
Shares outst. 0.000
Shares float 0.000 NaN%
Short % of float N/A
Short ratio N/A
1 year target N/A
Mean Recomm. N/A
Dividend $0.00
Dividend yield 0.00%
Payout ratio N/A
Payment date N/A
Ex-dividend date N/A
Earnings date N/A
IPO year 1998
Country N/A
Compare with other stocks

APEN
Apollo Endosurgery Inc
Compare

Market cap $391.37M
Enterprise value N/A
Revenue N/A
EBITDA N/A
Income -$39.84
Revenue Q/Q 31.80%
Revenue Y/Y 22.01%
P/E 0.00
Forward P/E N/A
EV/Sales 5.64
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 5.09
P/FCF N/A
Price/Book 12.01
Book/Share 0.83
Cash/Share N/A
FCF yield -8.57%
Employees 202
RPE N/A
Volume 1.640M / 0.000
Relative vol. N/A
EPS N/A
EPS Q/Q 136.36%
Est. EPS Q/Q 0.00%
Profit margin N/A
Oper. margin -40.88%
Gross margin N/A
EBIT margin -45.00%
EBITDA margin -60.86%
Ret. on assets -33.76%
Ret. on equity -89.48%
ROIC -28.61%
ROCE -48.92%
Debt/Equity N/A
Net debt/EBITDA -4.26
Current ratio 2.35
Quick ratio 1.89
Volatility 0.26%
Beta 0.00
RSI 66.09
Range $9.92 – $10.00
52 weeks $10.00 – $10.00
SMA 50 $10 +0.00%
SMA 200 $10 +0.00%
1 year target $5 -50.00%
Mean Recomm. N/A
Insider ownership 8.07%
Inst. ownership 73.50%
Shares outst. 57.972M
Shares float 0.000 0.00%
Short % of float 3.65%
Short ratio 12.39
1 year target $5 -50.00%
Mean Recomm. N/A
Dividend N/A
Dividend yield N/A
Payout ratio N/A
Payment date N/A
Ex-dividend date N/A
Earnings date N/A
IPO year 2012
Country United States
Compare with other stocks